FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
17/10/2023
Voltar para busca
Dado oficial do USPTO
VISISURE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
17/10/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10
Data de depósito
02/06/2022
Data de registro
20/06/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/06/2023
Última transação
20/06/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
25
Localização do titular
CH
Examinador
HSU, FONG
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word VISISURE to the right of a stylized check mark design comprised of a block outline of the letter "V".
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Classe 10
Drug delivery devicesnamely medical injection devices sold empty for administration of pharmaceutical preparations
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/09/2023
FIMP
FINAL DISPOSITION PROCESSED
26/09/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
20/09/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
20/06/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
20/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/04/2023
PUBO
PUBLISHED FOR OPPOSITION
04/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/02/2023
RFNT
REFUSAL PROCESSED BY IB
15/02/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/02/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/02/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/02/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/01/2023
RFRR
REFUSAL PROCESSED BY MPU
25/01/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
13/12/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
13/12/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
13/12/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
13/12/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
13/12/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
13/12/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
24/11/2022
CNRT
NON-FINAL ACTION WRITTEN
23/11/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2022
DOCK
ASSIGNED TO EXAMINER
07/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2022
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
02/11/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VISISURE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.